-
1
-
-
17044371509
-
Epidemiology of hepatocellular carcinoma. [v.]
-
PMID:15831268
-
Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. [v.]. Clin Liver Dis 2005; 9:191-211, v;PMID:15831268; http://dx.doi. org/10.1016/j.cld.2004.12.009
-
(2005)
Clin Liver Dis
, vol.9
, pp. 191-211
-
-
Bosch, F.X.1
Ribes, J.2
Cléries, R.3
Díaz, M.4
-
2
-
-
77954531753
-
Epidemiology of hepatocellular carcinoma
-
PMID:20616577
-
Sherman M. Epidemiology of hepatocellular carcinoma. Oncology 2010; 78(Suppl 1):7-10;PMID:20616577; http://dx.doi. or g/10.1159/000315223
-
(2010)
Oncology
, vol.78
, Issue.SUPPL. 1
, pp. 7-10
-
-
Sherman, M.1
-
3
-
-
20344392430
-
Hepatocellular carcinoma: Epidemiology, risk factors, and screening
-
PMID:15918143
-
Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25:143-54;PMID:15918143; http://dx.doi. org/10.1055/s-2005-871194
-
(2005)
Semin Liver Dis
, vol.25
, pp. 143-154
-
-
Sherman, M.1
-
4
-
-
84055193440
-
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?
-
PMID:21917086
-
Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res 2012; 42:1-14;PMID:21917086; http://dx.doi. org/10.1111/j.1872-034X.2011.00872.x
-
(2012)
Hepatol Res
, vol.42
, pp. 1-14
-
-
Hashimoto, E.1
Tokushige, K.2
-
5
-
-
77952580372
-
Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases
-
PMID:20460909
-
Powell EE, Jonsson JR, Clouston AD. Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Dig Dis 2010; 28:186-91;PMID:20460909; http://dx.doi. org/10.1159/000282084
-
(2010)
Dig Dis
, vol.28
, pp. 186-191
-
-
Powell, E.E.1
Jonsson, J.R.2
Clouston, A.D.3
-
6
-
-
79952303316
-
The etiology of hepatocellular carcinoma and consequences for treatment
-
PMID:21115577
-
Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010; 15(Suppl 4):14-22;PMID:21115577; http://dx.doi.org/10.1634/ theoncologist.2010-S4-14
-
(2010)
Oncologist
, vol.15
, Issue.SUPPL. 4
, pp. 14-22
-
-
Sanyal, A.J.1
Yoon, S.K.2
Lencioni, R.3
-
7
-
-
20344392430
-
Hepatocellular carcinoma: Epidemiology, risk factors, and screening
-
PMID:15918143
-
Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25:143-54;PMID:15918143; http://dx.doi. org/10.1055/s-2005-871194
-
(2005)
Semin Liver Dis
, vol.25
, pp. 143-154
-
-
Sherman, M.1
-
8
-
-
67650938571
-
Hepatocellular cancer: Optimal strategies for screening and surveillance
-
PMID:19546552
-
Cabibbo G, Craxì A. Hepatocellular cancer: optimal strategies for screening and surveillance. Dig Dis 2009; 27:142-7;PMID:19546552; http://dx.doi. org/10.1159/000218346
-
(2009)
Dig Dis
, vol.27
, pp. 142-147
-
-
Cabibbo, G.1
Craxì, A.2
-
9
-
-
77953156245
-
Epidemiology, risk factors and surveillance of hepatocellular carcinoma
-
PMID:20496547
-
Cabibbo G, Craxì A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2010; 14:352-5;PMID:20496547
-
(2010)
Eur Rev Med Pharmacol Sci
, vol.14
, pp. 352-355
-
-
Cabibbo, G.1
Craxì, A.2
-
10
-
-
77954218447
-
Molecularly targeted therapy in hepatocellular carcinoma
-
PMID:20371362
-
Huynh H. Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol 2010; 80:550-60;PMID:20371362; http://dx.doi.org/10.1016/j. bcp.2010.03.034
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 550-560
-
-
Huynh, H.1
-
11
-
-
57749191711
-
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis
-
Metroticket Investigator Study Group. PMID:19058754
-
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, et al.; Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10:35-43;PMID:19058754; http://dx.doi.org/10.1016/S1470-2045(08)70284-5
-
(2009)
Lancet Oncol
, vol.10
, pp. 35-43
-
-
Mazzaferro, V.1
Llovet, J.M.2
Miceli, R.3
Bhoori, S.4
Schiavo, M.5
Mariani, L.6
Camerini, T.7
Roayaie, S.8
Schwartz, M.E.9
Grazi, G.L.10
-
12
-
-
0141491273
-
Hepatocellular carcinoma
-
PMID:14667750
-
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-17;PMID:14667750; http://dx.doi.org/10.1016/S0140-6736(03)14964-1
-
(2003)
Lancet
, vol.362
, pp. 1907-1917
-
-
Llovet, J.M.1
Burroughs, A.2
Bruix, J.3
-
13
-
-
0038235271
-
Review article: Hepatocellular carcinoma: Indications for liver transplantation
-
PMID:12786624
-
Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther 2003; 17(Suppl 2):130-7;PMID:12786624; http://dx.doi. org/10.1046/j.1365-2036.17.s2.16.x
-
(2003)
Aliment Pharmacol Ther
, vol.17
, Issue.SUPPL. 2
, pp. 130-137
-
-
Mela, M.1
Mancuso, A.2
Burroughs, A.K.3
-
14
-
-
79957480596
-
Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma?
-
PMID:21307402
-
Vucur M, Roderburg C, Bettermann K, Tacke F, Heikenwalder M, Traut wein C, Luedde T. Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma? Oncotarget 2010; 1:373-8;PMID:21307402
-
(2010)
Oncotarget
, vol.1
, pp. 373-378
-
-
Vucur, M.1
Roderburg, C.2
Bettermann, K.3
Tacke, F.4
Heikenwalder, M.5
Traut Wein, C.6
Luedde, T.7
-
15
-
-
66149187115
-
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
-
REVEAL-HBV Study Group. PMID:19399801
-
Chen CJ, Yang HI, Iloeje UH; REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009; 49(Suppl):S72-84;PMID:19399801; http://dx.doi. org/10.1002/hep.22884
-
(2009)
Hepatology
, vol.49
, Issue.SUPPL.
-
-
Chen, C.J.1
Yang, H.I.2
Iloeje, U.H.3
-
16
-
-
59849093175
-
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
-
HALT-C Trial Group. PMID:18848939
-
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, et al.; HALT-C Trial Group. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009; 136:138-48; PMID:18848939; http://dx.doi.org/10.1053/j. gastro.2008.09.014
-
(2009)
Gastroenterology
, vol.136
, pp. 138-148
-
-
Lok, A.S.1
Seeff, L.B.2
Morgan, T.R.3
di Bisceglie, A.M.4
Sterling, R.K.5
Curto, T.M.6
Everson, G.T.7
Lindsay, K.L.8
Lee, W.M.9
Bonkovsky, H.L.10
-
17
-
-
0035133561
-
Bacterial translocation of enteric organisms in patients with cirrhosis
-
PMID:11211904
-
Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P, Fuster J, García-Valdecasas JC, Lacy A, Suárez MJ, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34:32-7;PMID:11211904; http://dx.doi. org/10.1016/S0168-8278(00)00013-1
-
(2001)
J Hepatol
, vol.34
, pp. 32-37
-
-
Cirera, I.1
Bauer, T.M.2
Navasa, M.3
Vila, J.4
Grande, L.5
Taurá, P.6
Fuster, J.7
García-Valdecasas, J.C.8
Lacy, A.9
Suárez, M.J.10
-
18
-
-
40049097359
-
Liver cirrhosis
-
PMID:18328931
-
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838-51;PMID:18328931; http://dx.doi. org/10.1016/S0140-6736(08)60383-9
-
(2008)
Lancet
, vol.371
, pp. 838-851
-
-
Schuppan, D.1
Afdhal, N.H.2
-
19
-
-
38749132020
-
Admixture mapping of white cell count: Genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies
-
PMID:18179887
-
Nalls MA, Wilson JG, Patterson NJ, Tandon A, Zmuda JM, Huntsman S, Garcia M, Hu D, Li R, Beamer BA, et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet 2008; 82:81-7;PMID:18179887; http://dx.doi.org/10.1016/j. ajhg.2007.09.003
-
(2008)
Am J Hum Genet
, vol.82
, pp. 81-87
-
-
Nalls, M.A.1
Wilson, J.G.2
Patterson, N.J.3
Tandon, A.4
Zmuda, J.M.5
Huntsman, S.6
Garcia, M.7
Hu, D.8
Li, R.9
Beamer, B.A.10
-
20
-
-
33749042572
-
The intestinal flora and bacterial infection in cirrhosis
-
PMID:16979776
-
Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 2006; 45:744-57;PMID:16979776; http://dx.doi. org/10.1016/j.jhep.2006.08.001
-
(2006)
J Hepatol
, vol.45
, pp. 744-757
-
-
Riordan, S.M.1
Williams, R.2
-
21
-
-
33645734597
-
Gut flora and bacterial translocation in chronic liver disease
-
PMID:16570339
-
Almeida J, Galhenage S, Yu J, Kurtovic J, Riordan SM. Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol 2006; 12:1493-502;PMID:16570339
-
(2006)
World J Gastroenterol
, vol.12
, pp. 1493-1502
-
-
Almeida, J.1
Galhenage, S.2
Yu, J.3
Kurtovic, J.4
Riordan, S.M.5
-
22
-
-
0028916769
-
Bacterial translocation and intestinal capillary permeability following major liver resection in the rat
-
PMID:7723311
-
Wang X, Pärsson H, Soltesz V, Johansson K, Andersson R. Bacterial translocation and intestinal capillary permeability following major liver resection in the rat. J Surg Res 1995; 58:351-8;PMID:7723311; http:// dx.doi.org/10.1006/jsre.1995.1054
-
(1995)
J Surg Res
, vol.58
, pp. 351-358
-
-
Wang, X.1
Pärsson, H.2
Soltesz, V.3
Johansson, K.4
Andersson, R.5
-
23
-
-
0037678893
-
Bacterial translocation after cirrhotic liver resection: A clinical investigation of 181 patients
-
PMID:12850464
-
Yeh DC, Wu CC, Ho WM, Cheng SB, Lu IY, Liu TJ, P'eng FK. Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients. J Surg Res 2003; 111:209-14;PMID:12850464; http://dx.doi.org/10.1016/S0022-4804(03)00112-4
-
(2003)
J Surg Res
, vol.111
, pp. 209-214
-
-
Yeh, D.C.1
Wu, C.C.2
Ho, W.M.3
Cheng, S.B.4
Lu, I.Y.5
Liu, T.J.6
P'eng, F.K.7
-
24
-
-
0028934072
-
Endotoxemia in patients with chronic liver diseases: Relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation
-
PMID:7790704
-
Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995; 22:165-72;PMID:7790704; http://dx.doi. org/10.1016/0168-8278(95)80424-2
-
(1995)
J Hepatol
, vol.22
, pp. 165-172
-
-
Lin, R.S.1
Lee, F.Y.2
Lee, S.D.3
Tsai, Y.T.4
Lin, H.C.5
Lu, R.H.6
Hsu, W.C.7
Huang, C.C.8
Wang, S.S.9
Lo, K.J.10
-
25
-
-
35948958955
-
TLR4 enhances TGF-beta signaling and hepatic fibrosis
-
PMID:17952090
-
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13:1324-32;PMID:17952090; http://dx.doi. org/10.1038/nm1663
-
(2007)
Nat Med
, vol.13
, pp. 1324-1332
-
-
Seki, E.1
De Minicis, S.2
Osterreicher, C.H.3
Kluwe, J.4
Osawa, Y.5
Brenner, D.A.6
Schwabe, R.F.7
-
26
-
-
33646347356
-
Toll-like r ec eptor signaling in the liver
-
PMID:16697751
-
Schwabe RF, Seki E, Brenner DA. Toll-like r ec eptor signaling in the liver. Gastroenterology 2006; 130:1886-900;PMID:16697751; http://dx.doi. org/10.1053/j.gastro.2006.01.038
-
(2006)
Gastroenterology
, vol.130
, pp. 1886-1900
-
-
Schwabe, R.F.1
Seki, E.2
Brenner, D.A.3
-
27
-
-
0038185316
-
Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells
-
PMID:12717385
-
Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37:1043-55;PMID:12717385; http://dx.doi. org/10.1053/jhep.2003.50182
-
(2003)
Hepatology
, vol.37
, pp. 1043-1055
-
-
Paik, Y.H.1
Schwabe, R.F.2
Bataller, R.3
Russo, M.P.4
Jobin, C.5
Brenner, D.A.6
-
28
-
-
33646862383
-
LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice
-
PMID:16439470
-
Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, Wheeler MD. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2006; 290:G1318-28;PMID:16439470; http://dx.doi. org/10.1152/ajpgi.00405.2005
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
-
-
Isayama, F.1
Hines, I.N.2
Kremer, M.3
Milton, R.J.4
Byrd, C.L.5
Perry, A.W.6
McKim, S.E.7
Parsons, C.8
Rippe, R.A.9
Wheeler, M.D.10
-
29
-
-
34548301514
-
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C
-
PMID:17461418
-
Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007; 46:297-306;PMID:17461418; http://dx.doi.org/10.1002/ hep.21695
-
(2007)
Hepatology
, vol.46
, pp. 297-306
-
-
Huang, H.1
Shiffman, M.L.2
Friedman, S.3
Venkatesh, R.4
Bzowej, N.5
Abar, O.T.6
Rowland, C.M.7
Catanese, J.J.8
Leong, D.U.9
Sninsky, J.J.10
-
30
-
-
73449143207
-
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
-
PMID:19850960
-
Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, Williams M, McFaline JL, Essigmann JM, Schauer DB, et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010; 59:88-97;PMID:19850960; http://dx.doi.org/10.1136/ gut.2009.183749
-
(2010)
Gut
, vol.59
, pp. 88-97
-
-
Fox, J.G.1
Feng, Y.2
Theve, E.J.3
Raczynski, A.R.4
Fiala, J.L.5
Doernte, A.L.6
Williams, M.7
McFaline, J.L.8
Essigmann, J.M.9
Schauer, D.B.10
-
31
-
-
79956260643
-
Distance burning: How gut microbes promote extraintestinal cancers
-
PMID:21637019
-
Rogers AB. Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes 2011; 2:52-7;PMID:21637019; http://dx.doi.org/10.4161/ gmic.2.1.14761
-
(2011)
Gut Microbes
, vol.2
, pp. 52-57
-
-
Rogers, A.B.1
-
32
-
-
73449143207
-
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
-
PMID:19850960
-
Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, Williams M, McFaline JL, Essigmann JM, Schauer DB, et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010; 59:88-97;PMID:19850960; http://dx.doi.org/10.1136/ gut.2009.183749
-
(2010)
Gut
, vol.59
, pp. 88-97
-
-
Fox, J.G.1
Feng, Y.2
Theve, E.J.3
Raczynski, A.R.4
Fiala, J.L.5
Doernte, A.L.6
Williams, M.7
McFaline, J.L.8
Essigmann, J.M.9
Schauer, D.B.10
-
33
-
-
10044289669
-
Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma
-
PMID:15563667
-
Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004; 57:1273-7;PMID:15563667; http://dx.doi.org/10.1136/ jcp.2004.018556
-
(2004)
J Clin Pathol
, vol.57
, pp. 1273-1277
-
-
Huang, Y.1
Fan, X.G.2
Wang, Z.M.3
Zhou, J.H.4
Tian, X.F.5
Li, N.6
-
34
-
-
14544280606
-
Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma
-
PMID:15710989
-
Rocha M, Avenaud P, Ménard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhães Queiroz DM, Mégraud F. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54:396-401;PMID:15710989; http://dx.doi.org/10.1136/gut.2004.042168
-
(2005)
Gut
, vol.54
, pp. 396-401
-
-
Rocha, M.1
Avenaud, P.2
Ménard, A.3
Le Bail, B.4
Balabaud, C.5
Bioulac-Sage, P.6
de Magalhães Queiroz, D.M.7
Mégraud, F.8
-
35
-
-
84930476752
-
Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma
-
PMID:22572832
-
Krüttgen A, Horz HP, Weber-Heynemann J, Vucur M, Traut wein C, Haase G, Luedde T, Roderburg C. Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma. Gut Microbes 2012; 3:228-33;PMID:22572832; http:// dx.doi.org/10.4161/gmic.19922
-
(2012)
Gut Microbes
, vol.3
, pp. 228-233
-
-
Krüttgen, A.1
Horz, H.P.2
Weber-Heynemann, J.3
Vucur, M.4
Traut Wein, C.5
Haase, G.6
Luedde, T.7
Roderburg, C.8
-
36
-
-
77957948007
-
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
-
PMID:20803560
-
Yu LX, Yan HX, Liu Q, Yang W, Wu HP, Dong W, Tang L, Lin Y, He YQ, Zou SS, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010; 52:1322-33;PMID:20803560; http://dx.doi. org/10.1002/hep.23845
-
(2010)
Hepatology
, vol.52
, pp. 1322-1333
-
-
Yu, L.X.1
Yan, H.X.2
Liu, Q.3
Yang, W.4
Wu, H.P.5
Dong, W.6
Tang, L.7
Lin, Y.8
He, Y.Q.9
Zou, S.S.10
-
37
-
-
84859812538
-
Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4
-
PMID:22516259
-
Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012; 21:504-16;PMID:22516259; http://dx.doi.org/10.1016/j.ccr.2012.02.007
-
(2012)
Cancer Cell
, vol.21
, pp. 504-516
-
-
Dapito, D.H.1
Mencin, A.2
Gwak, G.Y.3
Pradere, J.P.4
Jang, M.K.5
Mederacke, I.6
Caviglia, J.M.7
Khiabanian, H.8
Adeyemi, A.9
Bataller, R.10
-
38
-
-
84866383592
-
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
-
PMID:22727732
-
Zhang HL, Yu LX, Yang W, Tang L, Lin Y, Wu H, Zhai B, Tan YX, Shan L, Liu Q, et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 2012; 57:803-12;PMID:22727732; http://dx.doi.org/10.1016/j.jhep.2012.06.011
-
(2012)
J Hepatol
, vol.57
, pp. 803-812
-
-
Zhang, H.L.1
Yu, L.X.2
Yang, W.3
Tang, L.4
Lin, Y.5
Wu, H.6
Zhai, B.7
Tan, Y.X.8
Shan, L.9
Liu, Q.10
-
39
-
-
33845901507
-
Microbial ecology: Human gut microbes associated with obesity
-
PMID:17183309
-
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-3;PMID:17183309; http:// dx.doi.org/10.1038/4441022a
-
(2006)
Nature
, vol.444
, pp. 1022-1023
-
-
Ley, R.E.1
Turnbaugh, P.J.2
Klein, S.3
Gordon, J.I.4
-
40
-
-
84879888338
-
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
-
PMID:23803760
-
Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499:97-101;PMID:23803760; http://dx.doi.org/10.1038/nature12347
-
(2013)
Nature
, vol.499
, pp. 97-101
-
-
Yoshimoto, S.1
Loo, T.M.2
Atarashi, K.3
Kanda, H.4
Sato, S.5
Oyadomari, S.6
Iwakura, Y.7
Oshima, K.8
Morita, H.9
Hattori, M.10
-
41
-
-
77950240574
-
Gut flora and hepatic encephalopathy in patients with cirrhosis
-
PMID:20335591
-
Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 2010; 362:1140-2;PMID:20335591; http:// dx.doi.org/10.1056/NEJMe1000850
-
(2010)
N Engl J Med
, vol.362
, pp. 1140-1142
-
-
Riordan, S.M.1
Williams, R.2
-
42
-
-
77950246404
-
Rifaximin treatment in hepatic encephalopathy
-
PMID:20335583
-
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362:1071-81;PMID:20335583; http://dx.doi.org/10.1056/NEJMoa0907893
-
(2010)
N Engl J Med
, vol.362
, pp. 1071-1081
-
-
Bass, N.M.1
Mullen, K.D.2
Sanyal, A.3
Poordad, F.4
Neff, G.5
Leevy, C.B.6
Sigal, S.7
Sheikh, M.Y.8
Beavers, K.9
Frederick, T.10
|